HealthQuill Articles by: HealthQuill
The WHO’s rapid test will be used as the first method to diagnose tuberculosis and the global health agency will license one TB vaccine in a bid to reach 90% of the patients and to end the epidemic.
Drugs Health Pharma

WHO sets up body to develop, licence a new vaccine to fight tuberculosis

HQ Team September 23, 2023: The WHO’s rapid test will be used as the first method to diagnose tuberculosis and the global health

Read More
The global incidence of cholera doubled in 2022 year-on-year because rising floods, droughts and cyclones due to climate change triggered new outbreaks and worsened existing ones, a WHO report stated.
Climate Health Pharma

Cholera outbreaks worldwide rising as floods, droughts batter planet Earth

HQ Team September 23, 2023: The global incidence of cholera doubled in 2022 year-on-year because rising floods, droughts and cyclones due to climate

Read More
One person died and 14 others were suspected to have botulism in France, with chances of additional cases happening within the country or outside as the disease coincided with the Rugby World Cup.
Drugs Health Pharma

Botulism kills one in France during Rugby World Cup period

HQ Team September 21, 2023: One person died and 14 others were suspected to have botulism in France, with chances of additional cases

Read More
Uric acid may emerge as a potential therapy to treat ischemic stroke after US researchers discovered a new method in studies on animals.
Drugs Health Pharma

Uric acid a promising therapy for treating ischemic stroke: NIH research

HQ Team September 21, 2023: Uric acid may emerge as a potential therapy to treat ischemic stroke after US researchers discovered a new

Read More
US-based Pacific Northwest National Laboratory, Microsoft Corp., and Micron Technology have joined hands to make computational chemistry available to researchers and industrial users.
Drugs Health Pharma

PNNL ties up with Microsoft, Micron to help lab-to-market path quicker

HQ Team September 21, 2023: US-based Pacific Northwest National Laboratory, Microsoft Corp., and Micron Technology have joined hands to make computational chemistry available

Read More
An emergence of virulent diseases due to rising temperatures, a mass exodus of people fleeing wildfires and distressing scenes of farmers helplessly watching crops washed away are warning signals enough for governments to “hit the fast forward” on combatting climate change, the UN stated.
Climate Health Pharma

‘Humanity has opened the gates to hell,’ says UN chief Guterres

HQ Team September 21, 2023: An emergence of virulent diseases due to rising temperatures, a mass exodus of people fleeing wildfires and distressing

Read More
The US Department of Health and Human Services will award $45 million to clinics for expanding access and care to treat long COVID patients, especially in minority populations and the underserved.
Drugs Health Pharma

US to award $45 million in grants to clinics for treating long COVID-19

HQ Team September 20, 2023: The US Department of Health and Human Services will award $45 million to clinics for expanding access and

Read More
Elon Musk’s Neuralink Corp., got a nod from an independent institutional review board to start recruiting for a first-in-human trial to enable paralytic patients to control external devices with their thoughts.
Health Medical Pharma

Elon Musk’s Neuralink Corp gets nod to begin human trials 

HQ Team September 20, 2023: Elon Musk’s Neuralink Corp., got a nod from an independent institutional review board to start recruiting for a

Read More
Boston Scientific has acquired privately-held Relievant Medsystems, for more than $850 million to expand into the chronic low back pain segment.
Health Medical Pharma

Boston Scientific acquires Relevant Medsystems for $850m

HQ Team September 20, 2023: Boston Scientific has acquired privately-held Relievant Medsystems, for more than $850 million to expand into the chronic low

Read More
GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.
Drugs Health Pharma

GSK Plc gets EU approval for HIV prevention drug Apretude

GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.

Read More